SB-236057
SB-236057 is a pharmacological compound that acts as a selective antagonist for the 5-HT1B receptor. This receptor is a subtype of the 5-HT receptor that binds the neurotransmitter serotonin, also known as 5-hydroxytryptamine (5-HT).
Pharmacology[edit | edit source]
SB-236057 is a potent and selective 5-HT1B receptor antagonist. It has been used in scientific research to help understand the role of 5-HT1B receptors in various physiological and pathological processes. The compound has a high affinity for the 5-HT1B receptor, meaning it binds strongly to this receptor and blocks its activation by serotonin.
Chemistry[edit | edit source]
The chemical structure of SB-236057 is characterized by a dihydropyridine core, which is a common structural motif in many pharmacologically active compounds. The compound also contains a phenyl group and a piperazine ring, which contribute to its high affinity for the 5-HT1B receptor.
Applications[edit | edit source]
Research with SB-236057 has provided insights into the role of 5-HT1B receptors in various physiological processes, including neurotransmission, vasoconstriction, and platelet aggregation. The compound has also been used to investigate the involvement of 5-HT1B receptors in pathological conditions such as migraine, depression, and anxiety disorders.
See also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Admin, Prab R. Tumpati, MD